TGA provisional approval of Pfizer-BioNTech COVID-19 vaccine to include 12-15 year age group

TGA

23 July 2021 - The TGA has provisionally approved the use of the Pfizer BNT162b2 COVID-19 vaccine (Comirnaty) in individuals 12 years and older. 

Previously, the Pfizer COVID-19 vaccine was provisionally approved for use in individuals 16 years or older.

Read TGA News

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Australia , Paediatrics , COVID-19